# Trial of Transcatheter Arterial Chemoembolization (TACE) With Sorafenib for Locally Advanced Hepatocellular Carcinoma (HCC)

> **NCT01170104** · PHASE2 · UNKNOWN · sponsor: **Chung-Ang University** · enrollment: 63 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** Sorafenib
- **PROCEDURE:** TACE (Transcatheter arterial chemoembolization)

## Key facts

- **NCT ID:** NCT01170104
- **Lead sponsor:** Chung-Ang University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-06
- **Primary completion:** 2012-05
- **Final completion:** 2013-06
- **Target enrollment:** 63 (ESTIMATED)
- **Last updated:** 2011-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01170104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01170104, "Trial of Transcatheter Arterial Chemoembolization (TACE) With Sorafenib for Locally Advanced Hepatocellular Carcinoma (HCC)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01170104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*